Storyline
Takeda plans major restructuring to fund drug launches and pipeline development
Takeda is preparing a significant restructuring effort aimed at streamlining operations and achieving $1.2 billion in cost savings by 2028. The move, driven by the new CEO, will support upcoming drug launches and late-stage pipeline projects.
Evidence locked
Today's free sample is only available for the edition's flagship storyline.
Evidence preview
- Fierce Pharmafiercepharma.com
- Takeda is setting the stage for a sweeping new round of restructuring, aiming to streamline operations to bankroll up...Fierce Biotech
- Takeda Layoff (via Reddit)biotech